New WHO panel to speed up pandemic response, address shortcomings

Geneva- The World Health Organization‘s governing board agreed on Monday to form a new committee to help speed up its response to health emergencies like COVID-19.

The U.N. health agency faced criticism for its handling of the COVID-19 pandemic, including the pace of its response to early cases that may have delayed detection and helped the virus to spread. Some disease experts say that governments and the WHO must avoid repeating such early missteps with other outbreaks like monkeypox.

The resolution https://apps.who.int/gb/ebwha/pdf_files/EB151/B151_CONF1-en.pdf, passed unanimously at the 34-member Executive Board’s annual meeting, will form a new ‘Standing Committee on Health Emergency Prevention, Preparedness and Response’ to help address some of the perceived shortcomings.

Formal WHO meetings are sometimes spaced months apart and, under the new initiative, the new body would meet immediately after the Director-General declares a Public Health Emergency of International Concern (PHEIC) – a decision that triggers calls for extra funding, public health measures and a series of recommendations aimed at controlling disease spread.

“This was probably one of the weakest points during the last pandemic that member states or governing bodies didn’t have the opportunity to have immediate consultations after this PHEIC of the last pandemic was declared,” Austria’s Clemens Martin Auer, who proposed the resolution, told the Executive Board.

He added that the new committee would also conduct oversight of the WHO’s health emergencies programme in ordinary times to ensure it is fit to respond.

“I think the standing committee will be an indispensable part of the new global architecture on health emergency,” he added. The United States, the European Union, the United Kingdom and Japan were among the co-sponsors of the initiative.

  • Related Posts

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

    GLP-1 injections recalled across the US over sterility concerns

    A nationwide recall of compounded tirzepatide injections in the United States has raised fresh concerns about the safety of weight-loss medicines. The recall, initiated by Apothecary Pharma LLC over concerns…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    GLP-1 injections recalled across the US over sterility concerns

    GLP-1 injections recalled across the US over sterility concerns

    Govt allows third-party agencies to conduct departmental inspections

    Govt allows third-party agencies to conduct departmental inspections

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher